(Q37074994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

0 references

0 references

extensively drug-resistant tuberculosis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Therese Hesketh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

John Yudkin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

Transactions of the Royal Society of Tropical Medicine and Hygiene

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

219-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

The effect of drug resistance on the fitness of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Extensively drug resistant tuberculosis: beware patients lost to follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Early bactericidal activity of antituberculosis agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Increasing transparency in partnerships for health--introducing the Green Light Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Multidrug-resistant tuberculosis at an HIV testing center in Haiti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

XDR tuberculosis spreads across South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

HIV-TB: epidemiology, clinical features and diagnosis of smear-negativeTB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Multidrug-resistant tuberculosis management in resource-limited settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Biomarkers of treatment response in clinical trials of novel antituberculosis agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Multidrug-resistant tuberculosis: eight years of surveillance in France.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Tuberculosis drug development pipeline: progress and hope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Limited good and limited vision: multidrug-resistant tuberculosis and global health policy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

Global incidence of multidrug-resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.11.014

10.1016/J.TRSTMH.2007.11.014

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18243260%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference